616 results on '"López-Campos, José Luis"'
Search Results
52. Contributors
53. Phenotyping COPD
54. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (GesEPOC): The Epoconsul Study
55. Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL
56. Incidence of Interstitial Lung Diseases in the South of Spain 1998-2000: The RENIA Study
57. The variability of respiratory symptoms and associated factors in COPD
58. Occupational and Biomass Exposure in COPD: Results of a Cross-Sectional Analysis of the On-Sint Study
59. Exposición laboral y a biomasa en la enfermedad pulmonar obstructiva crónica: resultados de un análisis transversal del estudio On-Sint
60. Exacerbations in COPD: a personalised approach to care
61. Untargeted metabolomic study of lung cancer patients after surgery with curative intent: possible metabolites of good prognosis, intervention failure and recurrence
62. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.
63. Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group
64. Long-term prognostic capacity of multi-comorbid indices in chronic obstructive pulmonary disease
65. In Search for Simplicity: Quantifying the Diagnostic Algorithm of Hypersensitivity Pneumonitis
66. Randomized trial of non-invasive ventilation combined with exercise training in patients with chronic hypercapnic failure due to chronic obstructive pulmonary disease
67. Inter-Regional Changes in the Performance and Interpretation of Spirometry in Spain: 3E Study
68. Cambios interregionales en la realización e interpretación de las espirometrías en España: estudio 3E
69. Influence of Staff Training on the Outcome of Noninvasive Ventilation for Acute Hypercapnic Respiratory Failure
70. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
71. Inflammatory response in human lung cells stimulated with plasma from COPD patients
72. Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study
73. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives
74. Factors associated with high healthcare resource utilisation among COPD patients
75. Chronic Obstructive Pulmonary Disease History Assessment in Spain: A Multidimensional Chronic Obstructive Pulmonary Disease Evaluation. Study Methods and Organization
76. Chronic obstructive pulmonary disease History Assessment in Spain: una valoración multidimensional de la enfermedad pulmonar obstructiva crónica. Método y organización del trabajo
77. Consensus Document on the Overlap Phenotype COPD–Asthma in COPD
78. Documento de consenso sobre el fenotipo mixto EPOC-asma en la EPOC
79. Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
80. Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
81. Factors Associated With Hospital Admission for Exacerbation of Chronic Obstructive Pulmonary Disease
82. Factores asociados a la hospitalización por exacerbación de la enfermedad pulmonar obstructiva crónica
83. [Translated article] Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200
84. Las unidades de deshabituación tabáquica como oportunidad para el diagnóstico de EPOC: el proyecto 1000-200
85. Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review
86. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine
87. Effectiveness of a Cognitive Orientation Program With and Without Nicotine Replacement Therapy in Stopping Smoking in Hospitalised Patients
88. Efectividad de un programa de orientación cognitiva con y sin tratamiento sustitutivo con nicotina en la cesación tabáquica en pacientes hospitalizados
89. Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine
90. WITHDRAWN: Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
91. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
92. Global burden of COPD
93. Clinical Audit of Patients Admitted to Hospital in Spain due to Exacerbation of COPD (AUDIPOC Study): Method and Organisation
94. Training of Pulmonologists in Overseas Centers: A Resident's Experience
95. Importancia y variabilidad de los síntomas en la EPOC. Su importancia para el tratamiento
96. Formación neumológica en centros extranjeros. A propósito de una estancia
97. Testing for occult cancer in patients with pulmonary embolism: Results from a screening program and a two-year follow-up survey
98. Enabling a Community Approach to Respiratory Diseases: The HACER COPD Project
99. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
100. Baseline characteristics of patients enrolled in the EARCO prospective registry of alpha-1 antitrypsin deficiency: preliminary results
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.